All In Biotech

Drug Trial Radar · NCT06773962

A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease

A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease

Last checked: Nov 19, 2026Latest source record: Apr 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

62

Planned (sponsor's estimate)

Start

Mar 20, 2025

Primary completion

Nov 28, 2026

Study completion Nov 28, 2026

Sponsor

Lead sponsor
TrueBinding, Inc.Industry
Sponsor type
Industry
First posted
Jan 14, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).

Conditions

  • Parkinson's Disease (PD)

Interventions

  • TB006Drug

    IV infusion.

  • PlaceboDrug

    IV infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Parkinson's Disease Rating Scale ScoreTime frame: Baseline to 28 weeks
  2. Number of Participants Experiencing Adverse EventsTime frame: 28 weeks
  3. Number of Participants Experiencing Serious Adverse EventsTime frame: 28 weeks

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Parkinson's Research Centers of America - Orange County

    Aliso Viejo, California

  • Parkinson's Research Centers of America - Palo Alto

    Palo Alto, California

  • CenExel Rocky Mountain Clinical Research

    Englewood, Colorado

  • Parkinson's Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida

  • University of Miami

    Miami, Florida

  • University of South Florida Parkinson's and Movement Disorders Center

    Tampa, Florida

  • Consultants in Neurology, Ltd

    Northbrook, Illinois

  • Josephson Wallack Munshower Neurology - Southeast

    Indianapolis, Indiana

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Quest Research Institute

    Farmington Hills, Michigan

  • Parkinson's Research Centers of America - Long Island

    Commack, New York

  • NYU Langone Health

    Patchogue, New York

  • Oregon Health & Science University

    Portland, Oregon

  • Central Texas Neurology Consultants

    Round Rock, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.